Biosimilar Newsletter Archive

  1. 07.20.17 -- How Congress Can Help Biosimilars Succeed
    7/20/2017
    07/20/17 Biosimilar Development Newsletter
  2. 07.13.17 -- How Retail Pharmacies Are Approaching Biosimilars
    7/13/2017
    07/13/17 Biosimilar Development Newsletter
  3. 07.06.17 -- How Will Biosimilars Play Out In IDNs?
    7/6/2017
    07/06/17 Biosimilar Development Newsletter
  4. 06.29.17 -- How Biosimilars Are Challenging The FDA Beyond The Science
    6/29/2017
    06/29/17 Biosimilar Development Newsletter
  5. 06.27.17 -- Complying With The FDA While Modernizing Technology
    6/27/2017
    06/27/17 Biosimilar Development Newsletter
  6. 06.22.17 -- Political Uncertainty Spurs Push For Accelerated Biosimilar Development
    6/22/2017
    06/22/17 Biosimilar Development Newsletter
  7. 06.20.17 -- 5 Key Considerations For Expanding Biomanufacturing Capacity
    6/20/2017
    06/20/17 Biosimilar Development Newsletter
  8. 06.15.17 -- Biosimilar Pharmacovigilance: What Progress Has Been Made?
    6/15/2017
    06/15/17 Biosimilar Development Newsletter
  9. 06.08.17 -- Why Interchangeability Won't Be The "Silver Bullet" For Biosimilar Uptake
    6/8/2017
    06/08/17 Biosimilar Development Newsletter
  10. 06.01.17 -- What To Think About A 70% Biosimilar Discount
    6/1/2017
    06/01/17 Biosimilar Development Newsletter